Finance Watch: AbCellera, 4DMT, Nanobiotix IPOs Bring In $775m Combined
Post-ASH Offerings Also Bring In Big Bucks
Executive Summary
Public Company Edition: Lilly’s COVID-19 antibody partner AbCellera launched one of the biggest IPOs of 2020, bringing in $483m. Also, two more SPACs went public; Sinovac, Biocryst and Kura Oncology arranged large financings; and Viatris plans post-merger layoffs.